Five-Year Follow-Up After Ibrutinib Therapy for First-Line Treatment of Chronic Lymphocytic Leukemia

著录项

• 来源
  《Clinical lymphoma, myeloma & leukemia》 |2019年第1期|共1页
• 作者

  Burger Jan; Tedeschi Alessandra; Barr Paul M.; Robak Tadeusz; Owen Carolyn; Ghia Paolo; Bairey Osnat; Hillmen Peter; Coutre Steven E.; Devereux Stephen; Grosicki Sebastian; McCarthy Helen; Li Jianyong; Simpson David; Offner Fritz; Moreno Carol; Dai Sandra; Lal Indu; Dean James P.; Kipps Thomas J.;

  展开▼
• 作者单位

  Univ Texas MD Anderson Canc Ctr Dept Leukemia Houston TX 77030 USA;

  ASST Grande Osped Metropolitano Niguarda Milan Italy;

  Univ Rochester Med Ctr Wilmot Canc Inst Rochester NY 14642 USA;

  Med Univ Lodz Copernicus Mem Hosp Lodz Poland;

  Univ Calgary Tom Baker Canc Ctr Calgary AB Canada;

  Univ Vita Salute San Raffaele Milan Italy;

  Rabin Med Ctr Petah Tiqwa Israel;

  Leeds Teaching Hosp St James Inst Oncol Leeds W Yorkshire England;

  Stanford Univ Sch Med Stanford Canc Ctr Stanford CA 94305 USA;

  NHS Fdn Trust Kings Coll Hosp London England;

  Silesian Med Univ Sch Publ Hlth Katowice Poland;

  Royal Bournemouth Gen Hosp Bournemouth Dorset England;

  Jiangsu Prov Hosp Nanjing Jiangsu Peoples R China;

  North Shore Hosp Auckland New Zealand;

  Univ Ziekenhuis Gent Ghent Belgium;

  Autonomous Univ Barcelona Hosp Santa Creu &

  St Pau Barcelona Spain;

  Pharmacyclics LLC Sunnyvale CA USA;

  Pharmacyclics LLC Sunnyvale CA USA;

  Pharmacyclics LLC Sunnyvale CA USA;

  UCSD Moores Canc Ctr San Diego CA USA;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 肿瘤学;
• 关键词

  ibrutinib; long-term follow up; chlorambucil; targeted therapy; CLL; chronic lymphocytic leukemia;

  机译：Ibrutinib;长期跟进;氯镁;靶向治疗;CLL;慢性淋巴细胞白血病;